245 related articles for article (PubMed ID: 34022928)
1. Optical tissue measurements of invasive carcinoma and ductal carcinoma in situ for surgical guidance.
de Boer LL; Kho E; Van de Vijver KK; Vranken Peeters MTFD; van Duijnhoven F; Hendriks BHW; Sterenborg HJCM; Ruers TJM
Breast Cancer Res; 2021 May; 23(1):59. PubMed ID: 34022928
[TBL] [Abstract][Full Text] [Related]
2. Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.
Langhans L; Jensen MB; Talman MM; Vejborg I; Kroman N; Tvedskov TF
JAMA Surg; 2017 Apr; 152(4):378-384. PubMed ID: 28002557
[TBL] [Abstract][Full Text] [Related]
3. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
4. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
[TBL] [Abstract][Full Text] [Related]
5. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
[TBL] [Abstract][Full Text] [Related]
6. The radiological excision of high risk and malignant lesions using the INTACT breast lesion excision system. A case series with an imaging follow up of at least 5 years.
Allen SD; Osin P; Nerurkar A
Eur J Surg Oncol; 2014 Jul; 40(7):824-9. PubMed ID: 24742589
[TBL] [Abstract][Full Text] [Related]
7. Location and extent of positive resection margins and ductal carcinoma in situ in lumpectomy specimens of ductal breast carcinoma examined with a microscopic three-dimensional view.
Mai KT; Perkins DG; Mirsky D
Breast J; 2003; 9(1):33-8. PubMed ID: 12558668
[TBL] [Abstract][Full Text] [Related]
8. Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study.
Doebar SC; van den Broek EC; Koppert LB; Jager A; Baaijens MHA; Obdeijn IAM; van Deurzen CHM
Breast Cancer Res Treat; 2016 Jul; 158(1):179-187. PubMed ID: 27318854
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging system for intraoperative margin assessment for DCIS and invasive breast cancer using the ClearSight™ system in breast-conserving surgery-Results from a postmarketing study.
Thill M; Szwarcfiter I; Kelling K; van Haasteren V; Kolka E; Noelke J; Peles Z; Papa M; Aulmann S; Allweis T
J Surg Oncol; 2022 Mar; 125(3):361-368. PubMed ID: 34724205
[TBL] [Abstract][Full Text] [Related]
10. Positive surgical margins after breast-conserving surgery for ductal carcinoma in-situ: does histologic grade or estrogen receptor status matter?
Fauveau LR; Dao TN; Wallace LB; Mamawala MK; Obaid A; Waddimba AC; Grant MD
Breast Cancer Res Treat; 2023 Jun; 199(2):215-220. PubMed ID: 37027122
[TBL] [Abstract][Full Text] [Related]
11. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
12. The impact of field cancerization on the extent of duct carcinoma in situ (DCIS) in breast tissue after conservative excision.
Asioli S; Morandi L; Cavatorta C; Cucchi MC; Foschini MP
Eur J Surg Oncol; 2016 Dec; 42(12):1806-1813. PubMed ID: 27546014
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of breast MRI for surgical decision in patients with breast cancer: ductal carcinoma in situ versus invasive ductal carcinoma.
Lee J; Jung JH; Kim WW; Park CS; Lee RK; Kim HJ; Kim WH; Park HY
BMC Cancer; 2020 Sep; 20(1):934. PubMed ID: 32993586
[TBL] [Abstract][Full Text] [Related]
14. Long-term Results After Oncoplastic Surgery for Breast Cancer: A 10-year Follow-up.
Clough KB; van la Parra RFD; Thygesen HH; Levy E; Russ E; Halabi NM; Sarfati I; Nos C
Ann Surg; 2018 Jul; 268(1):165-171. PubMed ID: 28448389
[TBL] [Abstract][Full Text] [Related]
15. Lack of definitive presurgical pathological diagnosis is associated with inadequate surgical margins in breast-conserving surgery.
Nasute Fauerbach PV; Tyryshkin K; Rodrigo SP; Rudan J; Fichtinger G; Reedijk M; Varma S; Berman DM
Eur J Surg Oncol; 2021 Oct; 47(10):2483-2491. PubMed ID: 34120811
[TBL] [Abstract][Full Text] [Related]
16. Margins in breast cancer: How much is enough?
Pilewskie M; Morrow M
Cancer; 2018 Apr; 124(7):1335-1341. PubMed ID: 29338088
[TBL] [Abstract][Full Text] [Related]
17. Management of ductal carcinoma in situ with nipple discharge. Intraductal spreading of carcinoma is an unfavorable pathologic factor for breast-conserving surgery.
Ohuchi N; Furuta A; Mori S
Cancer; 1994 Aug; 74(4):1294-302. PubMed ID: 8055451
[TBL] [Abstract][Full Text] [Related]
18. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
Renshaw AA; Derhagopian RP; Martinez P; Gould EW
Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
[TBL] [Abstract][Full Text] [Related]
19. Preoperative breast MRI in management of patients with needle biopsy-proven ductal carcinoma in situ (DCIS).
van Bekkum S; Ter Braak BPM; Plaisier PW; van Rosmalen J; Menke-Pluijmers MBE; Westenend PJ
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1854-1860. PubMed ID: 32624292
[TBL] [Abstract][Full Text] [Related]
20. Does Mammographic Density have an Impact on the Margin Re-excision Rate After Breast-Conserving Surgery?
Edwards BL; Guidry CA; Larson KN; Novicoff WM; Harvey JA; Schroen AT
Ann Surg Oncol; 2016 Mar; 23(3):782-8. PubMed ID: 26471488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
